What is Organon's return on equity?

Organon (OGN) reported return on equity of 71.6% in Q3 2025.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Organon OGN Return on equity

Return on equity at other companies

PfizerPFE

10.6%—

AmgenAMGN

101.3%-4.4pp

The Cooper Companies, Inc.COO

2.9%-2.3pp

BiogenBIIB

8%-1.2pp

AbbVieABBV

89%+32.7pp

Amneal Pharmaceuticals, Inc.AMRX

-52.8%-12.7pp

Other financials

Income statement

See full

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

See full

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

See full

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

See full

Market cap$3.53B-59.4%

Enterprise value$10.98B-26.4%

P/E6.6×+2.1×

P/S0.6×-0.8×

Profitability

See full

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

See full

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Calculated from Organon’s reported figures.

net income/total stockholders equity=71.6%

Based on trailing twelve months.

The official record: Organon’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Organon's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organon's return on equity?: Organon (OGN) reported return on equity of 71.6% in Q3 2025.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.